# Vitonnix Raises First Institutional Seed Funding Led by Inflection Point Ventures

> Vitonnix raised its first institutional seed round led by Inflection Point Ventures, with doctors and actors participating.

- Published: 2026-10-15T19:22:09+00:00
- Section: Funding
- Author: News Desk
- URL: https://newsforagent.com/news/2026-10-15/vitonnix-first-institutional-seed-inflection-point
- Source: [Bwdisrupt](https://www.bwdisrupt.com/article/vitonnix-raises-first-institutional-funding-led-by-inflection-point-ventures-628857)

## Key takeaways

- Vitonnix raised its first institutional seed funding round led by Inflection Point Ventures, with participation from practising doctors and actors Riteish Deshmukh and Boman Irani.
- The company will use the funds to strengthen its senior leadership team, expand consumer acquisition and distribution, and support international expansion.
- Vitonnix is preparing to launch an initial range of 10 products with British retailer Boots in the UK in 2026.

Vitonnix has raised its first institutional investment in a seed funding round led by [Inflection Point Ventures](https://akta.pro/company-profiles/00000gt/inflection-point-ventures), with participation from practising doctors, actors Riteish Deshmukh and Boman Irani, singer Jaspinder Narula and film producer Madhu Mantena, [Bwdisrupt](https://www.bwdisrupt.com/article/vitonnix-raises-first-institutional-funding-led-by-inflection-point-ventures-628857) reported. The company will use the funds to strengthen its senior leadership team, expand consumer acquisition and distribution, and support international expansion.

## Vitonnix's SubliSpray Platform and Tata Group Support

Founded by three practising doctors, Prashant Jindal, Deepti Jindal and Rajesh Handa, [Vitonnix](https://akta.pro/company-profiles/006hj91/vitonnix) develops SubliSpray, a range of sublingual nutritional sprays initially developed in the UK and scaled in India. The products are designed to deliver nutrients through the oral mucosa. The company said it spent more than a decade developing the platform and has completed three clinical studies on key formulations.

Vitonnix's research, formulation and manufacturing operations are based in India, while its global operations are managed from London and Birmingham in the UK. Its precision spray systems are engineered in Germany, and patent applications have been filed for its bottle designs and formulations. The company said it has sold millions of bottles and has undertaken product registrations, regulatory filings and market-entry work across India, the UK, the US and the UAE.

In India, the company said its early market entry received support from the Tata group, followed by a co-branded product range within the Tata ecosystem. [Tata Group](https://akta.pro/company-profiles/0002z2a/tata-group) chairman N Chandrasekaran said innovation is critical as the conglomerate expands into semiconductors, batteries, renewable energy, and quantum computing, CNBC TV18 reported on October 7, 2026.

Dr Sandeep Gupta, director of orthopaedics at Max Hospitals, leads Vitonnix's medical team in India and is part of its core leadership, the company said. IPV has invested more than Rs 900 crore across over 280 startups and backed 16 startups in the first quarter of 2026, according to the announcement.

## Vitonnix's Distribution and Product Records

According to akta.pro [company records](https://akta.pro/company-data), Vitonnix secured an exclusive distribution partnership with Tata 1mg, India's leading online pharmacy platform, providing privileged shelf placement in a regulated pharmacy channel in addition to direct D2C sales. The company expanded its product portfolio to 15+ SKUs across six categories, including a dedicated Brain & Heart Vitality line for adult cognitive and cardiovascular positioning. Vitonnix also launched a celebrity endorsement campaign featuring Indian film personality Rakesh Roshan to build mass-market brand awareness in the Indian consumer nutraceutical category.

| Record | Figure |
| --- | --- |
| Product portfolio | 15+ SKUs across six categories |
| Self-reported engagement | 1.3 million+ sprays |
| Targeted wellness solutions | 20+ |

## Vitonnix's Boots Launch and International Plans

Vitonnix is preparing to launch an initial range of 10 products with British retailer Boots in the UK in 2026. The company has also expanded into companion-animal healthcare through Vetonnix, a nutritional spray platform for pets, with an initial range covering skin and coat care, calming support, multivitamins, growth and development, and bone and joint health. Vitonnix plans to continue expanding in India and use the UK as a gateway to Europe, with retail distribution, healthcare partnerships and regulatory expansion among its priorities.

## Companies in this story

- [Vitonnix company profile](https://akta.pro/company-profiles/006hj91/vitonnix) · website: https://vitonnix.in
- [Tata Group company profile](https://akta.pro/company-profiles/0002z2a/tata-group) · website: https://www.tata.com
- [Inflection Point Ventures company profile](https://akta.pro/company-profiles/00000gt/inflection-point-ventures) · website: https://ipventures.in

---
News for Agent · https://newsforagent.com/llms.txt